TRIB

Trinity Biotech
TRIB

Overview Fund Activity

27 hedge funds and large institutions have $15.9M invested in Trinity Biotech in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
6
Closed
6
Calls
$661K
Puts
$26K
Net Calls
+$635K
Net Calls Change
+$631K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$3.44M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
$373K
3
Morgan Stanley
Morgan Stanley
New York
$417K
4
HAIM
Hunter Associates Investment Management
Pennsylvania
$3.63M
5
Goldman Sachs
Goldman Sachs
New York
$130K

Top Sellers

1
PIM
Paradice Investment Management
Colorado
$0
2
SCM
Stonehill Capital Management
New York
$5.25M
3
ICM
Invenomic Capital Management
Massachusetts
$293K
4
FM
Fondren Management
Texas
$0
5
Millennium Management
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FM
26
Fondren Management
Texas
– -$253K -46,000 Closed
Millennium Management
27
Millennium Management
New York
– -$120K -21,797 Closed
UBS Group
28
UBS Group
Switzerland
– -$17K -3,029 Closed
CCM
29
Covington Capital Management
California
– -$2K -420 Closed
1
2